BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 24776847)

  • 1. Corticotropin-releasing hormone receptors mediate apoptosis via cytosolic calcium-dependent phospholipase A₂ and migration in prostate cancer cell RM-1.
    Jin L; Li C; Li R; Sun Z; Fang X; Li S
    J Mol Endocrinol; 2014 Jun; 52(3):255-67. PubMed ID: 24776847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urocortin affects migration of hepatic cancer cell lines via differential regulation of cPLA2 and iPLA2.
    Zhu C; Sun Z; Li C; Guo R; Li L; Jin L; Wan R; Li S
    Cell Signal; 2014 May; 26(5):1125-34. PubMed ID: 24518041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urocortin increased endothelial ICAM1 by cPLA2-dependent NF-κB and PKA pathways in HUVECs.
    Wan R; Liu Y; Li L; Zhu C; Jin L; Li S
    J Mol Endocrinol; 2014 Feb; 52(1):43-53. PubMed ID: 24363440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRH suppressed TGFβ1-induced Epithelial-Mesenchymal Transition via induction of E-cadherin in breast cancer cells.
    Jin L; Chen J; Li L; Li C; Chen C; Li S
    Cell Signal; 2014 Apr; 26(4):757-65. PubMed ID: 24412750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide urocortin and its receptors are expressed in rat Kupffer cells.
    Charalampopoulos I; Androulidaki A; Minas V; Chatzaki E; Tsatsanis C; Notas G; Xidakis C; Kolios G; Kouroumalis E; Margioris AN; Gravanis A
    Neuroendocrinology; 2006; 84(1):49-57. PubMed ID: 17090973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticotropin-releasing hormone receptor type 1 and type 2 mediate differential effects on 15-hydroxy prostaglandin dehydrogenase expression in cultured human chorion trophoblasts.
    Gao L; He P; Sha J; Liu C; Dai L; Hui N; Ni X
    Endocrinology; 2007 Aug; 148(8):3645-54. PubMed ID: 17463062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of corticotropin-releasing hormone family peptides in androgen receptor and vitamin D receptor expression and translocation in human breast cancer MCF-7 cells.
    Jin L; Chen C; Guo R; Wan R; Li S
    Eur J Pharmacol; 2012 Jun; 684(1-3):27-35. PubMed ID: 22494987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different effects of corticotropin-releasing factor and urocortin 2 on apoptosis of prostate cancer cells in vitro.
    Jin L; Zhang Q; Guo R; Wang L; Wang J; Wan R; Zhang R; Xu Y; Li S
    J Mol Endocrinol; 2011 Oct; 47(2):219-27. PubMed ID: 21765100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of urocortin and corticotropin-releasing hormone receptors in the horse thyroid gland.
    Squillacioti C; De Luca A; Alì S; Paino S; Liguori G; Mirabella N
    Cell Tissue Res; 2012 Oct; 350(1):45-53. PubMed ID: 22684850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticotropin-releasing hormone receptor (CRHR)1 and CRHR2 are both trafficking and signaling receptors for urocortin.
    Tu H; Kastin AJ; Pan W
    Mol Endocrinol; 2007 Mar; 21(3):700-11. PubMed ID: 17170072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated CRH receptors inhibit autophagy by repressing conversion of LC3BI to LC3BII.
    Jin L; Qian Y; Zhou J; Dai L; Cao C; Zhu C; Li S
    Cell Signal; 2019 Jun; 58():119-130. PubMed ID: 30849520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of corticotropin-releasing hormone receptor antagonists on the ethanol-induced increase of dynorphin A1-8 release in the rat central amygdala.
    Lam MP; Gianoulakis C
    Alcohol; 2011 Nov; 45(7):621-30. PubMed ID: 21840158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogens downregulate urocortin 2 expression in rat uterus.
    Watanabe K; Nemoto T; Akira S; Takeshita T; Shibasaki T
    J Endocrinol; 2013 Dec; 219(3):269-78. PubMed ID: 24109089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticotropin-releasing hormone receptors mediate opposing effects in cholestasis-induced liver cell apoptosis.
    Paschos KA; Charsou C; Constantinidis TC; Anagnostoulis S; Lambropoulou M; Papachristou F; Simopoulos K; Chatzaki E
    Endocrinology; 2010 Apr; 151(4):1704-12. PubMed ID: 20189999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stress-induced changes in gene expression of urocortin 2 and other CRH peptides in rat adrenal medulla: involvement of glucocorticoids.
    Tillinger A; Nostramo R; Kvetnansky R; Serova L; Sabban EL
    J Neurochem; 2013 Apr; 125(2):185-92. PubMed ID: 23320836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of urocortin and corticotropin-releasing hormone receptors in the bovine adrenal gland.
    Squillacioti C; De Luca A; Liguori G; Paino S; Mirabella N
    Gen Comp Endocrinol; 2011 Jul; 172(3):416-22. PubMed ID: 21504748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urocortin 2 role in placental and myometrial inflammatory mechanisms at parturition.
    Voltolini C; Battersby S; Novembri R; Torricelli M; Severi FM; Petraglia F; Norman JE
    Endocrinology; 2015 Feb; 156(2):670-9. PubMed ID: 25426872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of urocortin and its receptors in the rat epididymis.
    De Luca A; Liguori G; Squillacioti C; Paino S; Germano G; Alì S; Mirabella N
    Reprod Biol; 2014 Apr; 14(2):140-7. PubMed ID: 24856473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UCN2: a new candidate influencing pancreatic β-cell adaptations in pregnancy.
    Simpson SJS; Smith LIF; Jones PM; Bowe JE
    J Endocrinol; 2020 May; 245(2):247-257. PubMed ID: 32106091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRHR2/Ucn2 signaling is a novel regulator of miR-7/YY1/Fas circuitry contributing to reversal of colorectal cancer cell resistance to Fas-mediated apoptosis.
    Pothoulakis C; Torre-Rojas M; Duran-Padilla MA; Gevorkian J; Zoras O; Chrysos E; Chalkiadakis G; Baritaki S
    Int J Cancer; 2018 Jan; 142(2):334-346. PubMed ID: 28929494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.